Cognito Therapeutics, Inc.

medical devices

About

Cognito Therapeutics, Inc. is a medical technology company based in Cambridge, Massachusetts, focused on developing innovative therapies for neurodegenerative diseases, particularly Alzheimer’s disease. Founded in 2016, the company utilizes advanced research in neuroscience and optogenetics to create non-invasive treatments aimed at enhancing cognitive and functional abilities in patients. The core technology of Cognito Therapeutics involves gamma wave stimulation, which targets abnormal neuronal activity associated with Alzheimer’s. Their investigational therapeutic platform is delivered through a wearable headset that provides visual and auditory sensory stimulation to evoke gamma wave activity. This approach has shown promising results in clinical trials, including a significant slowing of brain volume loss and functional decline in patients with mild to moderate Alzheimer’s disease. The device has received FDA Breakthrough Device Designation, highlighting its potential to meet critical medical needs in Alzheimer’s treatment.

Technologies

Outlook Amazon AWS Google Tag Manager Vimeo Mobile Friendly Greenhouse.io Remote

Keywords

medical equipment manufacturing white matter preservation brain health brain activity modulation brain health technology alzheimers disease brain plasticity brain function support brain function preservation brain health innovation mit neuroscience research neuroplasticity enhancement brain health biomarkers neuroscience brain wave therapy sensory stimulation device gamma waves brain atrophy slowing medical devices neurotherapeutics neurodegenerative therapy home-based treatment b2c biotechnology brain stimulation therapy brain volume loss reduction d2c healthcare brain wave stimulation brain health clinical research

Location

1218 Massachusetts Ave, Cambridge, Massachusetts, United States, 02138-3821

Related Companies

Companies in the same industry